CompletedNCT01905423

Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis

Studying Filariasis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Washington University School of Medicine
Principal Investigator: Peter U Fischer, Ph.D.
Washington University School of Medicine
Intervention: Albendazole (annual)(drug)
Enrollment: 17108 enrolled
Eligibility: 5 years · All sexes
Timeline: 2011 – 2015

Study locations (1)

University of Indonesia, Department of Parasitology, Jakarta, Java, Indonesia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01905423 on ClinicalTrials.gov

Other trials for Filariasis

Additional recruiting or active studies for the same condition.

RECRUITINGNCT00001230
Host Response to Infection and Treatment in Filarial Diseases
National Institute of Allergy and Infectious Diseases (NIAID)

See all trials for Filariasis →

← Back to all trials